WGS
GeneDx Holdings Corp. · Healthcare · Medical - Diagnostics & Research
Momentum inputs (comparable managers):
holder breadth +8.3% ·
share flow -5.3% ·
net new positions +7.7%
· formula
Ownership fragmentation: more holders, smaller aggregate stake
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q4 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 88 | -5 | 15.43M | $1.06B | +10 | −14 |
| Q1 2026 | 95 | +2 | 15.21M | $977.50M | +14 | −13 |
| Q4 2025 | 94 | +1 | 15.07M | $1.96B | +3 | −1 |
| Q3 2025 | 16 | -1 | 7.41M | $798.15M | +2 | −4 |
| Q2 2025 | 15 | -1 | 4.67M | $430.80M | +1 | −2 |
| Q1 2025 | 13 | 0 | 2.11M | $186.46M | n/a | n/a |
| Q4 2024 | 13 | +1 | 1.90M | $146.41M | +2 | −1 |
| Q3 2024 | 11 | +4 | 1.69M | $71.81M | +4 | n/a |
| Q2 2024 | 7 | n/a | 992.14K | $25.94M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passive) | 382.35K | +1.2% | $29.40M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 2 | State Street Global Advisors ✦ (passive) | 319.91K | n/a | $24.59M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | D. E. Shaw & Co. ✦ | 294.52K | +838.2% | $22.64M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 4 | Renaissance Technologies ✦ | 205.12K | +119.2% | $15.77M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Two Sigma Investments ✦ | 152.07K | +276.3% | $11.69M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | Wellington Management ✦ | 140.79K | New | $10.82M | 0.0% | New | 1 | SEC ↗ ×3 |
| 7 | Citadel Advisors ✦ | 79.09K | +165.4% | $6.08M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 8 | Norges Bank ✦ (passive) | 68.00K | New | $5.23M | 0.0% | New | 1 | SEC ↗ |
| 9 | T. Rowe Price ✦ | 66.97K | +5.3% | $5.15M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 10 | Point72 Asset Management ✦ | 63.09K | -78.5% | $4.85M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 11 | Millennium Management ✦ | 58.80K | -89.8% | $4.52M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 57.53K | -34.2% | $4.42M | 0.0% | ▼ Trim | 2 | SEC ↗ ×3 |
| 13 | Gotham Asset Management ✦ | 16.59K | +23.1% | $1.27M | 0.0% | ▲ Add | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Wellington Management | $10.82M | 0.0% |
| Norges Bank | $5.23M | 0.0% |
Exited
| Marshall Wace | $3.67M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 240 holders, 31.22M shares, $1.98B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer, Director · 3.04K sh · $300,846
Officer · 1.08K sh · $106,816
Officer, Director · 1.65K sh · $155,337
Officer, Director · 148 sh · $14,120
Officer, Director · 1.52K sh · $147,774
Officer, Director · 4.14K sh · $406,936
Officer · 586 sh · $55,235
Officer · 52 sh · $4,961
Officer · 541 sh · $52,423
Officer · 1.47K sh · $144,457
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology
1.8% of class · View original SEC filing ↗